Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Aerosol Interleukin-2 for Pulmonary Metastases

NCT01590069 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT01590069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01590069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Aerosol Interleukin-2 for Pulmonary Metastases
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
June 28, 2012
Completion date
April 30, 2029
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the lung, metastatic melanoma, metastatic osteosarcoma, metastatic renal cell cancer, sarcoma, stage iv cutaneous melanoma ajcc v6 and v7, stage iv osteosarcoma ajcc v7, stage iv renal cell cancer ajcc v7